Literature DB >> 8621665

Biogenesis of the covalently flavinylated mitochondrial enzyme dimethylglycine dehydrogenase.

A Otto1, M Stoltz, H P Sailer, R Brandsch.   

Abstract

Rat dimethylglycine dehydrogenase (Me2GlyDH) was used as model protein to study the biogenesis of a covalently flavinylated mitochondrial enzyme. Here we show that: 1) enzymatically active holoenzyme correlated with trypsin resistance of the protein; 2) folding of the reticulocyte lysate-translated protein into the trypsin-resistant, holoenzyme form was a slow process that was stimulated by the presence of the flavin cofactor and was more efficient at 15 degrees C than at 30 degrees C; 3) the mitochondrial presequence reduced the extent but did not prevent holoenzyme formation; 4) covalent attachment of FAD to the Me2GlyDH apoenzyme proceeded spontaneously and did not require a mitochondrial protein factor; 5) in vitro only the precursor, but not the mature form, of the protein was imported into isolated rat liver mitochondria; in vivo, in stably transfected HepG2 cells, both the precursor and the mature form were imported into the organelle; 6) holoenzyme formation in the cytoplasm did not prevent the translocation of the proteins into the mitochondria in vivo; and 7) lack of vitamin B2 in the tissue culture medium resulted in a reduced recovery of the precursor and the mature form of Me2GlyDH from cell mitochondria, suggesting a decreased efficiency of mitochondrial protein import.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8621665     DOI: 10.1074/jbc.271.16.9823

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Anti-mitochondrial antibodies in patients with dilated cardiomyopathy (anti-M7) are directed against flavoenzymes with covalently bound FAD.

Authors:  A Otto; I Stähle; R Klein; P A Berg; S Pankuweit; R Brandsch
Journal:  Clin Exp Immunol       Date:  1998-03       Impact factor: 4.330

2.  Cloning of dimethylglycine dehydrogenase and a new human inborn error of metabolism, dimethylglycine dehydrogenase deficiency.

Authors:  B A Binzak; R A Wevers; S H Moolenaar; Y M Lee; W L Hwu; J Poggi-Bach; U F Engelke; H M Hoard; J G Vockley; J Vockley
Journal:  Am J Hum Genet       Date:  2001-02-28       Impact factor: 11.025

3.  Enzymic formation of riboflavin 4',5'-cyclic phosphate from FAD: evidence for a specific low-Km FMN cyclase in rat liver1.

Authors:  F J Fraiz; R M Pinto; M J Costas; M Aavalos; J Canales; A Cabezas; J C Cameselle
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

Review 4.  Covalent attachment of flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) to enzymes: the current state of affairs.

Authors:  M Mewies; W S McIntire; N S Scrutton
Journal:  Protein Sci       Date:  1998-01       Impact factor: 6.725

5.  Coxsackievirus B3 infection induces anti-flavoprotein antibodies in mice.

Authors:  G Cicek; T Vuorinen; I Stähle; P Stepanek; N Freudenberg; R Brandsch
Journal:  Clin Exp Immunol       Date:  2000-12       Impact factor: 4.330

6.  Molecular basis of dimethylglycine dehydrogenase deficiency associated with pathogenic variant H109R.

Authors:  R P McAndrew; J Vockley; J-J P Kim
Journal:  J Inherit Metab Dis       Date:  2008-10-21       Impact factor: 4.982

7.  Remaining challenges in cellular flavin cofactor homeostasis and flavoprotein biogenesis.

Authors:  Teresa A Giancaspero; Matilde Colella; Carmen Brizio; Graziana Difonzo; Giuseppina M Fiorino; Piero Leone; Roderich Brandsch; Francesco Bonomi; Stefania Iametti; Maria Barile
Journal:  Front Chem       Date:  2015-04-22       Impact factor: 5.221

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.